News Search Results
Feb 19, 2026, 16:05 ET Tyra Biosciences to Participate in Upcoming Investor Conferences
CARLSBAD, Calif., Feb. 19, 2026 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology,
More news about: Tyra Biosciences
Feb 19, 2026, 12:20 ET Antivenom Market to Reach $691.0 Million, Globally, by 2033 at 6.7% CAGR: Allied Market Research
foster the growth of the market. Technological innovation also plays a major role in the growth of the antivenom market.Advancements in biotechnology, including recombinant antibody technologies, monoclonal antibody approaches, and synthetic venom neutralizers also foster the growth of antivenom
More news about: Allied Market Research
Feb 19, 2026, 12:15 ET Patients with Crohn's disease maintained steroid-free remission for three years with Lilly's Omvoh (mirikizumab-mrkz)
life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
Feb 19, 2026, 11:58 ET Bio Decontamination Market to Reach $525.4 million by 2033 Globally, at 8.7% CAGR: Allied Market Research
isolators, pass-through chambers, and controlled production environments.Pharmaceutical and biotechnology companies dominated the industry in 2023By end user, the pharmaceutical and biotechnology companies segment accounted for the largest market share in 2023, owing to strict regulatory
More news about: Allied Market Research
Feb 19, 2026, 11:16 ET Cystatin C Assay Market to Reach $750.7 million, Globally, by 2033 at 7.4% CAGR: Allied Market Research
Immunofluorescence Assay, and Others), Sample Type (Blood, Urine), Application (Diagnostics, Research), End User (Hospitals, Pharmaceutical & Biotechnology Companies, and Others), and Region (North America, Europe, Asia-Pacific, LAMEA): Global Opportunity Analysis and Industry Forecast, 2024-2033".
More news about: Allied Market Research
Feb 19, 2026, 09:00 ET Merlin CP-GEP Becomes the First and Only Gene Expression Profile (GEP) Test Recommended by NCCN® Cutaneous Melanoma Guidelines to Assess Metastatic Risk
www.merlinmelanomatest.com.About SkylineDxSkylineDx is a biotechnology company focused on research and development of molecular diagnostics in oncology, and inflammatory and infectious diseases. SkylineDx uses its expertise
More news about: SkylineDx
Feb 19, 2026, 08:30 ET Lunai Bioworks (NASDAQ: LNAI) Locks Down Core AI Architecture with U.S. Patent Enabling Precision Disease Subtyping
SACRAMENTO, Calif., Feb. 19, 2026 /PRNewswire/ -- Lunai Bioworks, Inc. (NASDAQ: LNAI), an AI-driven biotechnology company advancing precision therapeutics in central nervous system (CNS) disorders and oncology, as well as solutions for biodefense, today announced
More news about: Lunai Bioworks Inc.
Feb 19, 2026, 08:00 ET NOVOS Core Clinical Trial Reveals Cardiovascular Benefits in Aging Adults
40+NEW YORK, Feb. 19, 2026 /PRNewswire/ -- NOVOS, a longevity-focused biotechnology company developing science-backed interventions for healthy aging, has announced results from a new randomized, double-blind, placebo-controlled
More news about: NOVOS Labs
Feb 19, 2026, 07:19 ET BPC Instruments secures order for BPC Blue system from global testing and certification group
(publ)BPC Instruments is a Swedish technology company developing analytical instruments for renewable bioenergy and environmental biotechnology, including biogas and biodegradability testing. The systems enable advanced testing with higher accuracy and consistency, while reducing the time
More news about: BPC Instruments AB
Feb 19, 2026, 06:15 ET Epson Robots to Exhibit at DesignCon, APEX and MAX in Early 2026
of experience, Epson Robots delivers robots for precision assembly and material handling applications in the aerospace, appliance, automotive, biotechnology, consumer product, electronics, food processing, medical device, pharmaceutical, plastics, semiconductor, and telecommunication industries. For
More news about: Epson America, Inc.
Feb 19, 2026, 03:38 ET Biodegradable Packaging Market to Reach USD 24.2B by 2036 (6.1% CAGR) | PLA Leads (41%) and Food Packaging Tops Demand (40%) | Growth Hotspots: China, India & Germany
that combine different performance characteristics (e.g., PBAT toughness with PLA rigidity). The report also notes growing acquisition interest in biotechnology startups to access microbial fermentation IP for PHA production, and increased collaboration with major CPG brands to pilot closed-loop composting
More news about: Future Market Insights
Feb 18, 2026, 20:47 ET NASDAQ: QURE: Kessler Topaz Meltzer & Check, LLP Files a Securities Fraud Class Action Lawsuit Against uniQure N.V.
speak with an attorney.UNIQURE N.V. CLASS ACTION LAWSUIT - COMPLAINT ALLEGATION SUMMARY: uniQure is a biotechnology company developing gene therapies for rare diseases, including Huntington's disease (HD). uniQure's leading drug candidate is AMT-130, a novel
More news about: Kessler Topaz Meltzer & Check, LLP
Feb 18, 2026, 16:43 ET RGNX Stockholder Alert: Robbins LLP Remind Investors of the Class Action Lawsuit Against REGENXBIO, Inc.
purchased or otherwise acquired REGENXBIO, Inc. (NASDAQ: RGNX) securities between February 9, 2022 and January 27, 2026. REGENXBIO is a clinical-stage biotechnology company providing gene therapies that deliver functional genes to cells with genetic defects in the United States.
More news about: Robbins LLP
Feb 18, 2026, 14:30 ET Human Longevity Launches Personal AI-Powered Longevity App
testing to continuous, personalized health risk management."About Human LongevityFounded in 2013, Human Longevity, Inc. is a biotechnology company at the forefront of integrating genomics, artificial intelligence, and multimodal diagnostics to extend human healthspan. Through its flagship
More news about: Human Longevity, Inc.
Feb 18, 2026, 13:45 ET Draper and the Northeast Microelectronics Coalition (NEMC) Announce Chip Design and Packaging Services to Accelerate Technology Commercialization
meet our customers' requirements. These efforts focus on four critical mission areas: Strategic Systems, Space Systems, Electronic Systems, and Biotechnology Systems. To extend our legacy into the future, the
More news about: Draper Laboratory
Feb 18, 2026, 12:00 ET Lifespan Vision Ventures Co-Leads Sift Biosciences' $3.7M Pre-Seed Financing
Directors. About Lifespan Vision Ventures Lifespan Vision Ventures is a global venture capital firm investing in early-stage biotechnology companies developing breakthrough technologies to prevent and treat age-related diseases. The firm partners with visionary founders advancing science-driven
More news about: LifeSpan Vision Ventures
Feb 18, 2026, 12:00 ET Lifespan Vision Ventures Co-Leads Sift Biosciences' $3.7M Pre-Seed Financing
Directors. About Lifespan Vision Ventures Lifespan Vision Ventures is a global venture capital firm investing in early-stage biotechnology companies developing breakthrough technologies to prevent and treat age-related diseases. The firm partners with visionary founders advancing science-driven
More news about: LifeSpan Vision Ventures
Feb 18, 2026, 11:46 ET Hydrophobic Interaction Chromatography Market to Reach $952.9 Million, Globally, by 2033 at 7.5% CAGR: Allied Market Research
during the forecast period. This is attributed to growing demand for high-quality chromatography products, particularly in biopharmaceuticals and biotechnology industries. The increasing use of hydrophobic interaction chromatography for the purification of monoclonal antibodies, therapeutic proteins, and
More news about: Allied Market Research
Feb 18, 2026, 11:16 ET Astaxanthin Market to Reach $1.6 Billion, Globally, by 2033 at 8.1% CAGR: Allied Market Research
rising health awareness, and growing demand for nutraceuticals and cosmetics in countries such as China, Japan, and India. Increasing investments in biotechnology and expanding middle-class population with higher disposable income further support regional growth.For Purchase Related Queries/Enquiry
More news about: Allied Market Research
Feb 18, 2026, 11:01 ET Egg White Substitute Market to Reach US$ 2.3 Billion by 2033 as Vegan & Functional Food Trends Drive Growth As per Persistence Market Research
Market by Product Type (Liquid Egg Whites, Liquid Egg Yolks, Liquid Whole Eggs), Source (Cage-free, Conventional), Application (Food Industry, Biotechnology, Cosmetic Industry), and Regional Analysis for 2025 - 2032About Persistence Market Research:At Persistence Market Research,
More news about: Persistence Market Research Pvt. Ltd.
Feb 18, 2026, 09:05 ET NeuroSense Announces Statistically Significant 65% Reduction in Risk of Death and Greater than 14-Month Median Survival Benefit with PrimeC in ALS
NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-stage clinical biotechnology company focused on developing disease-modifying treatments for neurodegenerative diseases, today announced the availability of additional long-term
More news about: NeuroSense
Feb 18, 2026, 09:00 ET GMP Labeling Partners with Loftware for Digital Label Solutions
integrate physical labels, label printers, and integrated software, addressing the evolving regulatory needs of medical device, pharmaceutical, and biotechnology industries.
More news about: GMP Labeling Inc.
Feb 18, 2026, 09:00 ET Medpace Holdings Under Investigation After Book-to-Bill Miss Exposes Cancellation Surge and Pipeline Fragility
research organizations (CROs) in the clinical-trial industry, providing Phase I through Phase IV drug development services to pharmaceutical and biotechnology companies worldwide. In the CRO sector, the book-to-bill ratio serves as the primary forward-looking indicator of business health. Because CRO revenues
More news about: Levi & Korsinsky, LLP
Feb 18, 2026, 09:00 ET ICON plc Faces Investigation After Internal Probe Reveals Multi-Year Revenue Overstatement
world's largest contract research organizations, providing outsourced drug development and clinical trial management services to pharmaceutical and biotechnology companies. The CRO industry relies on long-term service contracts that typically span multiple years, making accurate revenue recognition a critical
More news about: Levi & Korsinsky, LLP
Feb 18, 2026, 08:54 ET Iaso Therapeutics to Showcase Novel mQβ Vaccine Platform at 2026 World Vaccine Congress
EAST LANSING, Mich., Feb. 18, 2026 /PRNewswire/ -- Iaso Therapeutics, Inc., a biotechnology company redefining infectious disease prevention with its novel synthetic vaccine platform, today announced that it will present at the 2026 World
More news about: Iaso Therapeutics, Inc.